[ Price : $8.95]
In an unprecedented move, FDA issues a statement to clarify that data integrity or fraud is not at the center of why Sarepta Thera...[ Price : $8.95]
The HHS Office of the Inspector General announces its Work Plan for fiscal year 2015 that targets five FDA drug program areas.[ Price : $8.95]
FDA approves a Lannett Co. ANDA for letrozole tablets USP, 2.5 mg, a generic copy of Novartis Femara tablets.[ Price : $8.95]
FDAs Cardiovascular and Renal Drugs Advisory Committee recommends approval of Daiichi Sankyos once-daily Savaysa (edoxaban) 60 mg ...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on the FDA commis...[ Price : $8.95]
Federal Register Notice: FDA corrects a notice on exports and notification and recordkeeping requirements.[ Price : $8.95]
Federal Register Notice: FDA determines that several drug products were not withdrawn from sale for reasons of safety or effective...[ Price : $8.95]
FDA grants final approval to TWi Pharmaceuticals for its ANDA for a generic version of Eisais Aricept, 23 mg to treat Alzheimers d...